The results of transwell showed that overexpression of BFSP1 increased the invasion ability of liver cancer cells by 68%, whereas knockdown of TMOD4 reversed the promotion of overexpression of BFSP1 (Fig. 4j and Fig. S2j). The gene discussed is BFSP1; the disease is liver cancer.